Predictive impact of PI-RADS 3 lesion volume/total prostate volume ratio in prostate cancer diagnosis in biopsy-naïve patients
Turkish Journal of Medical Sciences · 12.12.2025 · 55 (6) · 1459-1465
DOI: 10.55730/1300-0144.6103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 12.12.2025. Verfasst von Emrah Özsoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Ünye Çakırtepe Hospital, Ordu, Turkiye. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Multiparametric Magnetic Resonance Imaging, Prostate. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/aim: To assess the potential of the ratio between PI-RADS 3 lesion volume and total prostate volume as a predictive parameter for guiding the decision to perform a biopsy in patients presenting with PI-RADS 3 lesions on multiparametric prostate magnetic resonance imaging (mpMRI). Materials and methods: A total of 749 patients who underwent mpMRI due to suspected prostate cancer between January 2014 and August 2023 were scanned. Based on predefined inclusion and exclusion criteria, 308 patients were included. Age, total prostate-specific antigen (PSA) value, prostate volume measured in mpMRI, mpMRI result, PI-RADS 3 lesion volume, and biopsy results were collected. The PI-RADS 3 ratio was calculated as PI-RADS 3 lesion volume/total prostate volume. PSA density (dPSA) was calculated. The patients were categorized according to their biopsy results as benign or malignant (subclassified by Gleason group grade), and the two groups were compared.
Results
The average PI-RADS 3 ratio was 0.032 ± 0.002. There were 230 (74.7%) patients in the benign group and 78 (25.3%) patients in the malignant group. There was a statistically significant difference detected in average prostate volumes (p < 0.001), dPSA values (p = 0.001), and PI-RADS 3 ratios (p < 0.001). The receiver operating curve analysis of PI-RADS 3 ratio indicated an area under the curve of 0.643 ± 0.037. The optimal cut-off point was 0.026 with a sensitivity of 58.97% and a specificity of 66.96%. A positive, albeit weak, statistically significant relationship was found between PIRADS-3 ratios and dPSA values (rs ρ = 0.261 and p < 0.001).
Conclusion
PI-RADS 3 ratio may serve as an auxiliary clinical parameter alongside age, dPSA, and lesion volume alone in identifying more refined candidates for biopsy in the goal of patient care individualization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Ünye Çakırtepe Hospital, Ordu, Turkiye.
- Department of Urology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara, Turkiye.
- Department of Urology, Haydarpaşa Numune Training and Research Hospital, Health Sciences University, İstanbul, Turkiye.
- Department of Urology, Van Training and Research Hospital, Health Sciences University, Van, Turkiye.
- Department of Radiology, Medistate Hospital, Beykoz University, İstanbul, Turkiye.
ORCID-Profile: Emrah Özsoy, Musab Ali Kutluhan, Emre Tokuç, Rıdvan Kayar, Samet Demir, Kaan Meriç, Metin İshak Öztürk
Zitieren
APA
Özsoy, E., Kutluhan, M. A., Tokuç, E., Kayar, R., Demir, S., Meriç, K., & Öztürk, M. İ. (2025). Predictive impact of PI-RADS 3 lesion volume/total prostate volume ratio in prostate cancer diagnosis in biopsy-naïve patients. Turkish Journal of Medical Sciences, 55(6), 1459-1465. https://doi.org/10.55730/1300-0144.6103
Vancouver
Özsoy E, Kutluhan MA, Tokuç E, Kayar R, Demir S, Meriç K, et al. Predictive impact of PI-RADS 3 lesion volume/total prostate volume ratio in prostate cancer diagnosis in biopsy-naïve patients. Turkish Journal of Medical Sciences. 2025;55(6):1459-1465. doi:10.55730/1300-0144.6103
BibTeX
@article{zsoy2025,
author = {Özsoy, Emrah and Kutluhan, Musab Ali and Tokuç, Emre and Kayar, Rıdvan and Demir, Samet and Meriç, Kaan and Öztürk, Metin İshak},
title = {Predictive impact of PI-RADS 3 lesion volume/total prostate volume ratio in prostate cancer diagnosis in biopsy-naïve patients},
journal = {Turkish Journal of Medical Sciences},
year = {2025},
volume = {55},
number = {6},
pages = {1459--1465},
doi = {10.55730/1300-0144.6103}
}
EUVIMED